These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4115244)

  • 1. Cyclophosphamide plus emetine in lung cancer.
    Hyde KR; Marsh K; Perry W
    Lancet; 1972 Aug; 2(7774):427. PubMed ID: 4115244
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclophosphamide plus emetine in lung cancer.
    Street EW
    Lancet; 1972 Aug; 2(7773):381-2. PubMed ID: 4114753
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase I-II evaluation of emetine (NSC-33669) in the treatment of epidermoid bronchogenic carcinoma.
    Kane RC; Cohen MH; Broder LE; Bull MI; Creaven PJ; Fossieck BE
    Cancer Chemother Rep; 1975; 59(6):1171-2. PubMed ID: 1222395
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].
    González Larriba JL; Ordóñez Gallego A; Díaz Pérez MA; García de Paredes ML; Zamora P; Montero García JM
    Med Clin (Barc); 1984 May; 82(19):836-9. PubMed ID: 6330470
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of chemotherapy as an adjuvant to surgery for bronchogenic carcinoma.
    Higgins GA
    Cancer; 1972 Nov; 30(5):1383-7. PubMed ID: 4343295
    [No Abstract]   [Full Text] [Related]  

  • 6. [MACC plus thymostimulin (TP-1 Serono) therapy of small cell bronchogenic carcinoma. Clinico-immunologic evaluation of the results of a randomized trial].
    Salvati F; Pallotta G; Antilli A; Nunziati F; De Marinis F; Lucchesi M
    G Ital Chemioter; 1984; 31(1-2):185-9. PubMed ID: 6088341
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prognostic factors in the chemotherapy of bronchial cancers].
    Alberto P
    Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
    [No Abstract]   [Full Text] [Related]  

  • 8. Ifosfamide: a weekly dose fractionated schedule in bronchogenic carcinoma.
    Morgan LR; Posey LE; Rainey J; Bickers J; Ryan D; Vial R; Hull EW
    Cancer Treat Rep; 1981; 65(7-8):693-5. PubMed ID: 6265084
    [No Abstract]   [Full Text] [Related]  

  • 9. [Early results of bronchogenic carcinoma treatment with massive doses of cyclophosphamide].
    Kochnowski G; Rozek G; Wisńiewski J
    Wiad Lek; 1976 Feb; 29(4):270-1. PubMed ID: 1251645
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cancer chemotherapy as a supplement to operation in bronchogenic carcinoma].
    Castberg T; Kruse-Blinkenberg HO
    Ugeskr Laeger; 1976 Jun; 138(24):1449-55. PubMed ID: 1273973
    [No Abstract]   [Full Text] [Related]  

  • 11. 5-Fluorouracil (NSC-19893) compared to cyclophosphamide (NSC-26271) in bronchogenic carcinoma: results of a clinical study.
    Brugarolas A; Rivas A; Lacave AJ; Gonzalez-Palacois F; Froufe A
    Cancer Chemother Rep; 1975; 59(5):1025-6. PubMed ID: 1106844
    [No Abstract]   [Full Text] [Related]  

  • 12. Heparin anticoagulation as adjuvant to chemotherapy in carcinoma of the lung.
    Elias EG
    J Med; 1974; 5(1):114-32. PubMed ID: 4364885
    [No Abstract]   [Full Text] [Related]  

  • 13. Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide.
    Johnson DH; Wolff SN; Hainsworth JD; Porter LL; Grosh WW; Hande KR; Greco FA
    J Clin Oncol; 1985 Feb; 3(2):170-5. PubMed ID: 2981981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial.
    Loehrer PJ; Birch R; Kramer BS; Greco FA; Einhorn LH
    Cancer Treat Rep; 1986 Jul; 70(7):919-20. PubMed ID: 3013402
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of small cell bronchogenic carcinoma with VM-26.
    Woods RL; Fox RM; Tattersall MH
    Cancer Treat Rep; 1979; 63(11-12):2011-3. PubMed ID: 230897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with emetine hydrochloride (NSC 33669) as an antitumor agent.
    Panettiere F; Coltman CA
    Cancer; 1971 Apr; 27(4):835-41. PubMed ID: 4929936
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship between myelosuppression and chemotherapeutic response in small cell bronchogenic carcinoma.
    Holoye PY
    Exp Hematol; 1985; 13 Suppl 16():72-9. PubMed ID: 2985416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical trial of cyclophosphamide (NSC-26271) and radiation therapy for oat cell carcinoma of the lung.
    Tucker RD; Sealy R; van Wyk C; le Roux PL; Soskolne CL
    Cancer Chemother Rep 3; 1973 Mar; 4(2):159-60. PubMed ID: 4354040
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination chemotherapy of bronchogenic carcinoma with cyclophosphamide (NSC-26271) and BCNU (NSC-409962).
    Curtis JE
    Cancer Chemother Rep; 1974; 58(6):883-8. PubMed ID: 4614897
    [No Abstract]   [Full Text] [Related]  

  • 20. Adriamycin and adriamycin--DNA in inoperable bronchogenic carcinoma. A randomized study with cyclophosphamide vinblastine.
    Bosly A; Prignot J; Ledent C; Sokal G; Trouet A
    Eur J Cancer (1965); 1978 Jun; 14(6):639-44. PubMed ID: 658087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.